AG00I6BT

32986-56-4 | Tobramycin

Chemical structure of Tobramycin, CAS 32986-56-4
AG00I6BT
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 32986-56-4
Catalog Number AG00I6BT(AGN-PC-0R8EQS)
Chemical Name Tobramycin
EC Number 251-322-5
IUPAC Name (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
InChI InChI=1S/C18H37N5O9/c19-3-9-8(25)2-7(22)17(29-9)31-15-5(20)1-6(21)16(14(15)28)32-18-13(27)11(23)12(26)10(4-24)30-18/h5-18,24-28H,1-4,19-23H2/t5-,6+,7+,8-,9+,10+,11-,12+,13+,14-,15+,16-,17+,18+/m0/s1
InChI Key NLVFBUXFDBBNBW-PBSUHMDJSA-N
MDL Number MFCD00077885
Molecular Formula C18H37N5O9
Molecular Weight 467.5145
NSC Number 757352
SMILES O[C@H]1[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@@H]3[C@H](N)C[C@H](O)[C@@H](CN)O3)[C@@H](N)C[C@H]2N)O[C@H](CO)[C@@H](O)[C@@H]1N
UNII VZ8RRZ51VK
Synonyms
Brulamycin, Nebcin, Nebicin, Nebramycin Factor 6, Obracin, Sulfate, Tobramycin, Tobracin, Tobramycin, Tobramycin Sulfate, tobramycin, 32986-56-4, Nebramycin factor 6, Nebramycin 6, Nebramycin VI, Tobracin, Tobramicin, Tobramycetin, 3'-Deoxykanamycin B, Tenebrimycin, Tobramitsetin, Tenemycin, Aktob, Tobrex, Tobi, Nebcin, Deoxykanamycin B, NEBRAMYCIN, Tobramycinum, Obramycin, Tobradex, Tobralex, Tobramicina, Tobramycine, Tobramycin Base, 1-Epitobramycin, TOBRAMYCIN SULFATE, Gotabiotic, Nebicin, Tobacin, Tobrased, Tobrasone, Tobradistin, Tobramaxin, Lilly 47663, UNII-VZ8RRZ51VK, Tobramycine [INN-French], Tobramycinum [INN-Latin], Tobramicina [INN-Spanish], Tobracin (TN), Distobram, Nebramycin factir 6, NSC 180514, Tobrex (TN), HSDB 3259, C18H37N5O9, EINECS 251-322-5, VZ8RRZ51VK, SPRC-AB01, BRN 1357507, CHEBI:28864, tobramycin solution for inhalation, NLVFBUXFDBBNBW-PBSUHMDJSA-N, Tobramycin, 97%, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-4))-2-deoxy-, Brulamycin, Tobi Podhaler, 4-(2,6-Diamino-2,3,6-trideoxy-alpha-D-glycopyranosyl)-6-(3-amino-3-deoxy-alpha-D-glycopyranosyl)-2-deoxystreptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine, Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-tyrideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-, Bethkis, Kitabis Pak, Gernebcin, (1S,2S,3R,4S,6R)-4,6-diamino-3-[(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside, (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxy-tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-6-(hydroxymethyl)tetrahydropyran-3,5-diol, (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol, 4-AMINO-2-[4,6-DIAMINO-3-(3-AMINO-6-AMINOMETHYL-5-HYDROXY-TETRAHYDRO-PYRAN-2-YLOXY)-2-HYDROXY-CYCLOHEXYLOXY]-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1-6))-2-deoxy-L-streptamine, Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-6))-2-deoxy-, D-, TOY, SR-05000001726, torbamycin, Sybryx, Tobramycin,(S), Nebcin (Sulfate), Tobramycin [USAN:BAN:INN:JAN], NCGC00016814-01, (2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-3-((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yloxy)-2-hydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, Bethkis (TN), CAS-32986-56-4, MFCD00077885, Nebramycin-Faktor 6, Tobramycin(free-base), Tobramycin [2M+H], Tobramycin [USAN:USP:INN:BAN:JAN], Tobi (TN), Spectrum_001072, AC1Q2AOW, Tobramycin for Inhalation, Prestwick3_000544, Spectrum2_000078, Spectrum3_000588, Spectrum4_000752, Spectrum5_001038, DSSTox_CID_3680, ro-2H-pyran-3,5-diol, Tobramycin (JP17/USP), AC1L1VI0, SCHEMBL2838, CHEMBL1747, DSSTox_RID_77144, DSSTox_GSID_23680, BSPBio_000587, BSPBio_002036, KBioGR_001104, KBioSS_001552, MLS000069544, BIDD:GT0503, SPECTRUM1500579, SPBio_000295, BPBio1_000647, DTXSID8023680, KBio2_001552, KBio2_004120, KBio2_006688, KBio3_001536, AOB5629, BIT0802, ZX-AFC000193, HMS2090B16, HMS2092M17, HMS2096N09, HMS3713N09, Pharmakon1600-01500579, HY-B0441, ZINC8214692, Tox21_110626, BDBM50366778, CCG-39936, NSC757352, s2514, AKOS016339662, AN-9578, API0004434, CS-2547, DB00684, KS-1405, NSC-757352, TOA-(1-6)TOB-(4-1)TOC, NCGC00178852-01, NCGC00178852-02, TOA-(1-6)2TB-(4-1)TOC, CC-35084, CPD000058793, SAM001246911, SC-45657, SMR000058793, SBI-0051915.P003, AB2000616, LS-146940, LS-187329, AB00513858, A-8891, C00397, D00063, J10405, AB00052438-12, AB00052438_13, AB00052438_14, 986T564, C-22669, SR-01000721898, Tobramycin, Antibiotic for Culture Media Use Only, Q-201837, SR-01000721898-2, SR-05000001726-1, SR-05000001726-2, BRD-K05619559-001-12-7, UNII-NQJ13I4Z9U component NLVFBUXFDBBNBW-PBSUHMDJSA-N, (1S,2S,3R,4S,6R)-4,6-diamino-3-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside, (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahyd, (2S,3R,4S,5S,6R)-4-amino-2-(((1S,2S,3R,4S,6R)-4,6-diamino-3-(((2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, (2S,3R,4S,5S,6R)-4-amino-2-{[(1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2R,3R,5S,6R)-3-amino-6-(aminomethyl)-5-hydroxyoxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxane-3,5-diol, D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribohexopyranosyl-(1->4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4))-2-deoxy-, O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-->4)]-2-deoxy-D-streptamine, O-[3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)]-O-[2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-?-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-?-D-ribohexopyranosyl-(1-4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-a-D-glucopyranosyl-(1-6)-O-[2,6-diamino-2,3,6-trideoxy-a -D-ribo-hexopyranosyl-(1-4)]-2-deoxy-D-streptamine, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1-4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribohexopyranosyl-(1-4))-2-deoxy-D-streptamine, vantobra, Obracin, null, Burlamycin, Mixture Name, Tobradex ST, Sulfate, Tobramycin, NF 6, Tobramycin [USAN:INN:BAN:JAN], TOBRAMYCIN AND DEXAMETHASONE, CID36294, RW2731, C18-H37-N5-O9, CS-O-02441, B1856, T2503, D014031, 79645-27-5, O(C1OC(CO)C(O)C(N)C1O)C2C(N)CC(N)C(OC3OC(CN)C(O)CC3N)C2O, >D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1?6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1?4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-? -D-glucopyranosyl-(1.fwdarw.6)-O-[2,6-diamino-2,3 ,6-trideoxy-?-D-ribo-hexopyranosyl-(1.fwdarw. 4)]-2-deoxy-, D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(16)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(14))-2-deoxy-, O-3-Amino-3-deoxy-alpha-D-glucopyranosyl-(1->4)-O-(2,6-diamino-2,3,6-trideoxy-alpha-D-ribo-hexopyranosyl-(1->6))-2-deoxy-L-streptamine, Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)-O-[2,6-diamino-2,3,6-trideoxy-.alpha.-D-ribo-hexopyranosyl-(1.fwdarw.6)]-2-deoxy-, D-, TOB,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited